Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01433692
Other study ID # CHU-0103
Secondary ID
Status Recruiting
Phase N/A
First received September 12, 2011
Last updated January 11, 2013
Start date March 2012
Est. completion date July 2014

Study information

Verified date January 2013
Source University Hospital, Clermont-Ferrand
Contact Patrick LACARIN
Phone 04 73 75 1195
Email placarin@chu-clermontferrand.fr
Is FDA regulated No
Health authority France: Ministry of Health
Study type Interventional

Clinical Trial Summary

Background: Cannabis is the most prevalent illegal drug used in France, and consequences arising from the step of 'casual consumers'(1-10 joints/month). Side effects of cannabis are now well documented: Trauma (driving after consuming cannabis), respiratory, cardiovascular diseases and psychiatric and social problems. The general practitioner (GP) is the health professional most viewed by adolescents. Brief interventions (BI) for adult alcohol use have been shown to be efficient. Some BI have been designed to inspect adolescents and consumption of cannabis have been piloted, showing their feasibility, but no test has validated them.

Aim : Does a BI conducted by general practitioners reduce consumption of canabis in 15 to 19 years old ?

Method:

Two preliminary qualitative studies (with adolescents and GP), were used to analyze the difficulties of communication around cannabis use. The Scientific Committee has analyzed the results and developed a workshop around BI, adapted to adolescents cannabis users.

CANABIC is a quantitative study to validate use of BI with cannabis users: a randomized controlled trial, clustered study, comparing an intervention group (IG) and a control group (CG). The intervention is the achievement of the IB during a specific consultation. The outcome is the consumption of cannabic (Number of joints / month).

The study will be carried out in 3 french regions : Auvergne, Rhône-Alpes and Languedoc-Roussillon. 150 GPs wil be recruited and randomized in intervention group or control group (ratio 1 :1).

Each GP will inlcude 5 adolescents (i.e. a total of 750 adolescents) - . The number of adolescents needed has been calculate with hypothesis of a significant difference of 30% in consumption of cannabis between adolescents who beneficied of BI (IG) and those who do not experienced BI ( CG) A pilot study has been conducted. Cannabis use by adolescents has decreased. Their perception of cannabis has changed: they are aware of the harmful effects of their consumption. This pilot study has improve many points of the protocol.

Results:

A decrease of 30% of consumption is expected (joints per month). Perception of cannabis by adolescents will be reviewed.

Conclusions:

To validate an IB adaptated to consultation with adolscents cannabis consumer in order to provide a tool for GP in their daily practice.


Description:

General organisation of the study

- Recruitment of the GP: 3 months (from December 2011 to March 2012)

- Training of the intervention group GP during a one-day training, in March 2012, on 3 thematic: relationship between GP and adolescent, cannabis and BI; by an expert team

- Inclusion period : 10 months (from April 2012 to January 2013). The included patients will be followed for 12 months. There are 3 follow up consultations at 3, 6 and 12 months.

- First consultation used to the inclusion:

Information to the patient and collection of the patient non opposition (without informing the intervention objectives in the control group).

Evaluation of cannabis consumption, but also tobacco and alcohol consumption. Collection of the perception of cannabis by adolescents, and its impact on health.

Inclusion criteriae : repetead users : 1 to 10 per month; regular users : 11 to 29 per month; daily users : 1 and more per day.

In the IG : achievment of the BI with the adolescent. In each group, making appointment with the patient at 3 months

• Follow up consultations : At 3, 6 and 12 months. Evaluation of cannabis consumption, but also tobacco and alcohol consumption. Collection of the perception of cannabis by adolescents, and its impact on health.


Recruitment information / eligibility

Status Recruiting
Enrollment 750
Est. completion date July 2014
Est. primary completion date March 2014
Accepts healthy volunteers No
Gender Both
Age group 15 Years to 25 Years
Eligibility Inclusion Criteria:

- Adolescents 15 to 25 years Repetead users : 1 to 10 per month; regular users : 11 to 29 per month; daily users : 1 and more per day.

The patient must have given his informed consent and signed the form of no objection

Exclusion Criteria:

- Adolescents with psychiatric illness considered by the attending physician in acute decompensated

- Intellectual Disability

- Hard of hearing

- No French language skills

- Patient already under treatment for the withdrawal of an addicition to cannabis or other substance

- Adolescents who participated in the preliminary qualitative study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)


Intervention

Behavioral:
Brief Intervention
CANABIC is a quantitative study to validate use of BI with cannabis users: a randomized controlled trial, clustered study, comparing an intervention group (IG) and a control group (CG). The intervention is the achievement of the IB during a specific consultation. The outcome is the consumption of cannabic (Number of joints / month).

Locations

Country Name City State
France CHU Clermont-Ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary the number of joints consumed per month at 12 months Yes
Secondary the number of joints consumed per month at 3 and at 6 months Yes
See also
  Status Clinical Trial Phase
Completed NCT03224858 - Ambulatory ICU Study for Medically and Socially Complex Patients N/A
Completed NCT03663075 - Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women N/A
Recruiting NCT04151056 - Impact of the Social Determinants of Health in the Central Catalan Region
Recruiting NCT05715151 - Continuous Quality Improvement Cohorts on Advanced Access N/A
Completed NCT01242319 - Translating ATP III Cholesterol Management Guidelines Into Primary Care Practice N/A
Recruiting NCT06155292 - Report Cards and Feedback for PCCE N/A
Completed NCT02955433 - The Impact of Rideshare Transportation Services on Appointment Adherence N/A
Completed NCT02266069 - PROject - Supportive and Palliative Care and INnOvation - Antwerp (Pro-Spinoza) N/A
Recruiting NCT04702711 - Experiences of Anger in Patients in Primary Health Care With Symptoms of Generalized Anxiety
Completed NCT04521816 - PIM 2.0: Patient Aligned Care Team (PACT) Intensive Management (PIM) Project N/A
Recruiting NCT05709860 - An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy N/A
Completed NCT05121688 - Effectiveness of a Physical Therapy Telerehabilitation Program in Long Post COVID-19 Symptoms in Primary Health Care. N/A
Completed NCT05329246 - Validation of PMcardio AI-assisted Clinical Assistant in Primary Care N/A
Completed NCT02953925 - National-wide Survey on Primary Health Care in China N/A
Completed NCT03100526 - Patient Aligned Care Team (PACT) Intensive Management (PIM) Project N/A
Active, not recruiting NCT04585191 - Reducing Treatment Risk in Older Adults With Diabetes N/A
Recruiting NCT05609981 - Optimising Medication With Focus on Deprescribing in Frail Older People With Multidose Drug Dispensing Systems N/A
Completed NCT04688359 - Effectiveness of Nurse-coordinated Follow-up Program in Primary Care for People at Risk for T2DM N/A
Completed NCT04237883 - Primary Care Clinical Excellence Incentive Study N/A
Withdrawn NCT04010136 - Identification of Elderly Patients in Need of Palliative Care by Family Physicians N/A